NCT03419494 2018-02-05
Comparison of Liposomal Doxorubicin and Daunorubicin-containing VDCLD Regimen in the Treatment of Adult ALL Patients
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
Unknown
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
H. Lee Moffitt Cancer Center and Research Institute